Evaluation of Stigma and Related Factors in Fibromyalgia

Gaziosmanpasa Research and Education Hospital

Status: Unknown

Conditions: Fibromyalgia

Study type: Observational

Funder types: Other

Identifiers

NCT04274036

13

Details and patient eligibility

About

Stigmatization is especially studied in mental disorders such as schizophrenia. In recent years, different chronic diseases such as AIDS, tuberculosis, and diabetes have also been shown to decrease in quality of life due to the "stigma" of these patients.

Full description

Stigmatization is especially studied in mental disorders such as schizophrenia. In recent years, different chronic diseases such as AIDS, tuberculosis, and diabetes have also been shown to decrease in quality of life due to the "stigma" of these patients. Fibromyalgia patients with chronic widespread body pain and accompanying subjective fatigue, depression, and anxiety; Although there is no objective pathology from the outside, it can be stigmatized in family life, work-life and health institutions they apply for the diagnosis of pain due to the intensive complaints. The fact that the subjective complaints seen without an objective pathology are so severe makes the management of these patients difficult. To reveal the presence of stigma in patients diagnosed with fibromyalgia compared with the healthy control group is the main aim of this study. It is the secondary purpose of this study to determine related factors such as gender, age, educational status, marital status, employment status, income level, pain duration, pain intensity, medications used, and social support received from patients' family and the environment. We hypothesize that this group of patients suffers more stigma and the quality of life decreases due to this stigma.

Enrollment: 108 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Patients over the age of 18
• To be diagnosed with fibromyalgia according to American College of Rheumatology 2016 revised criteria

Exclusion criteria

• Have been diagnosed and treated with fibromyalgia before
• Presence of any diagnosis that can cause secondary fibromyalgia (rheumatic diseases such as rheumatoid arthritis, ankylosing spondylitis)
• The presence of anemia
• Vitamin D deficiency
• Presence of known endocrine, neurological and cardiac diseases
• Antidepressant use

Trial design

108 participants in 2 patient groups

Fibromyalgia Patients

Description:

Fibromyalgia patients diagnosed according to the 2016 American College of Rheumatology criteria.

Healthy-Controls

Description:

Healthy controls without pain or chronic illness